Numans Health Food Holdings Company Limited (HKG:2530)
Hong Kong
· Delayed Price · Currency is HKD 0.600
+0.020 (3.45%)
At close: Mar 10, 2026
HKG:2530 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Revenue | 224.57 | 277.5 | 426.55 | 367.3 | 337.61 |
| Revenue Growth (YoY) | -40.99% | -34.94% | 16.13% | 8.79% | - |
| Cost of Revenue | 55.99 | 65.23 | 99.83 | 117.7 | 96.92 |
| Gross Profit | 168.58 | 212.27 | 326.71 | 249.59 | 240.69 |
| Selling, General & Admin | 105.13 | 111.94 | 124.41 | 94.07 | 79.49 |
| Other Operating Expenses | -9.39 | -9.39 | -2.21 | 52.77 | -3.75 |
| Operating Expenses | 95.74 | 102.55 | 122.2 | 146.84 | 75.74 |
| Operating Income | 72.84 | 109.72 | 204.51 | 102.76 | 164.95 |
| Interest Expense | -0.27 | -0.26 | -0.33 | -0.38 | -0.12 |
| Interest & Investment Income | 3.84 | 3.17 | 2.19 | 0.72 | 0.48 |
| Currency Exchange Gain (Loss) | -0.31 | -1.24 | 1.16 | 0.05 | -0.46 |
| Other Non Operating Income (Expenses) | -3.99 | - | - | -5.95 | -10.72 |
| EBT Excluding Unusual Items | 72.11 | 111.39 | 207.53 | 97.2 | 154.13 |
| Gain (Loss) on Sale of Assets | -0.01 | -0.01 | -0.02 | -0.09 | - |
| Legal Settlements | 0.18 | 0.18 | 0.06 | 1.31 | - |
| Other Unusual Items | -12.1 | -12.1 | -12.95 | - | - |
| Pretax Income | 60.18 | 99.47 | 194.62 | 98.41 | 154.13 |
| Income Tax Expense | 28.44 | 24.57 | 35.28 | 10.89 | 34.46 |
| Net Income | 31.75 | 74.9 | 159.34 | 87.52 | 119.67 |
| Net Income to Common | 31.75 | 74.9 | 159.34 | 87.52 | 119.67 |
| Net Income Growth | -75.07% | -53.00% | 82.06% | -26.86% | - |
| Shares Outstanding (Basic) | 868 | 750 | 750 | - | - |
| Shares Outstanding (Diluted) | 868 | 750 | 750 | - | - |
| EPS (Basic) | 0.04 | 0.10 | 0.21 | - | - |
| EPS (Diluted) | 0.04 | 0.10 | 0.21 | - | - |
| EPS Growth | -78.47% | -53.00% | - | - | - |
| Free Cash Flow | 65.13 | 82.33 | 150.36 | 43.11 | 93 |
| Free Cash Flow Per Share | 0.07 | 0.11 | 0.20 | - | - |
| Dividend Per Share | 0.050 | 0.050 | - | - | - |
| Gross Margin | 75.07% | 76.50% | 76.59% | 67.95% | 71.29% |
| Operating Margin | 32.44% | 39.54% | 47.95% | 27.98% | 48.86% |
| Profit Margin | 14.14% | 26.99% | 37.36% | 23.83% | 35.45% |
| Free Cash Flow Margin | 29.00% | 29.67% | 35.25% | 11.74% | 27.55% |
| EBITDA | 73.75 | 110.51 | 205.9 | 104.28 | 166.38 |
| EBITDA Margin | 32.84% | 39.83% | 48.27% | 28.39% | 49.28% |
| D&A For EBITDA | 0.91 | 0.8 | 1.39 | 1.52 | 1.44 |
| EBIT | 72.84 | 109.72 | 204.51 | 102.76 | 164.95 |
| EBIT Margin | 32.44% | 39.54% | 47.95% | 27.98% | 48.86% |
| Effective Tax Rate | 47.25% | 24.70% | 18.13% | 11.07% | 22.36% |
| Advertising Expenses | - | - | - | 31.2 | 25.56 |
Source: S&P Capital IQ. Standard template. Financial Sources.